Showing results (61-70 of 71) with videos related to
Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2019
Alterations in DNA Damage Repair Genes in Primary Liver CancerJianzhen Lin, Junping Shi, Honglin Guo, et al.Frontiers in Immunology|July 2, 2021
Targeted Next-Generation Sequencing Combined With Circulating-Free DNA Deciphers Spatial Heterogeneity of Resected Multifocal Hepatocellular CarcinomaJianzhen Lin, Songhui Zhao, Dongxu Wang, et al.Journal for Immunotherapy of Cancer|May 11, 2021
Cell-free DNA copy number variations predict efficacy of immune checkpoint inhibitor-based therapy in hepatobiliary cancersXu Yang, Ying Hu, Keyan Yang, et al.Biomarker Research|June 3, 2024
Gut microbiota and metabolites signatures of clinical response in anti-PD-1/PD-L1 based immunotherapy of biliary tract cancerChengpei Zhu, Yunchao Wang, Ruijuan Zhu, et al.Journal for Immunotherapy of Cancer|December 7, 2021
Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancersJinzhu Mao, Dongxu Wang, Junyu Long, et al.Frontiers in Immunology|December 26, 2022
Efficacy of immune checkpoint inhibitors plus molecular targeted agents after the progression of lenvatinib for advanced hepatocellular carcinomaFucun Xie, Bowen Chen, Xu Yang, et al.Hepatobiliary Surgery and Nutrition|August 25, 2020
Pembrolizumab combined with lenvatinib as non-first-line therapy in patients with refractory biliary tract carcinomaJianzhen Lin, Xu Yang, Junyu Long, et al.Hepatology (Baltimore, Md.)|December 10, 2025
Spatiotemporal landscape of intrahepatic cholangiocarcinoma liver metastasis at the single-cell levelZiyu Xun, Hao Wang, Zhengfeng Xuan, et al.Theranostics|March 23, 2021
Mutational spectrum and precision oncology for biliary tract carcinomaJianzhen Lin, Yinghao Cao, Xu Yang, et al.Hepatology International|February 8, 2023
Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patientsXu Yang, Bowen Chen, Yanyu Wang, et al.Pageof 8